Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

312 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Management of patients with rare adult solid cancers: objectives and evaluation of European reference networks (ERN) EURACAN.
Blay JY, Casali P, Ray-Coquard I, Seckl MJ, Gietema J, de Herder WW, Caplin M, Klümpen HJ, Glehen O, Wyrwicz L, Peeters R, Licitra L, Girard N, Piperno-Neumann S, Kapiteijn E, Idbaih A, Franceschi E, Trama A, Frezza AM, Hohenberger P, Hindi N, Martin-Broto J, Schell J, Rogasik M, Lejeune S, Oliver K, de Lorenzo F, Weinman A. Blay JY, et al. Among authors: idbaih a. Lancet Reg Health Eur. 2024 Feb 16;39:100861. doi: 10.1016/j.lanepe.2024.100861. eCollection 2024 Apr. Lancet Reg Health Eur. 2024. PMID: 38384730 Free PMC article. Review.
Health-related quality-of-life results from the randomised phase II TAVAREC trial on temozolomide with or without bevacizumab in 1p/19q intact first-recurrence World Health Organization grade 2 and 3 glioma (European Organization for Research and Treatment of Cancer 26091).
Reijneveld JC, Machingura A, Coens C, Taphoorn MJB, Taal W, Clement PM, Idbaih A, de Vos FYF, Klein M, Wick W, Mulholland PJ, Lewis J, Golfinopoulos V, Ghislain I, Bottomley A, van den Bent MJ; EORTC Brain Tumor Group. Reijneveld JC, et al. Among authors: idbaih a. Eur J Cancer. 2023 Sep;190:112946. doi: 10.1016/j.ejca.2023.112946. Epub 2023 Jun 19. Eur J Cancer. 2023. PMID: 37453240 Free article. Clinical Trial.
Deep-learning-based reconstruction of undersampled MRI to reduce scan times: a multicentre, retrospective, cohort study.
Rastogi A, Brugnara G, Foltyn-Dumitru M, Mahmutoglu MA, Preetha CJ, Kobler E, Pflüger I, Schell M, Deike-Hofmann K, Kessler T, van den Bent MJ, Idbaih A, Platten M, Brandes AA, Nabors B, Stupp R, Bernhardt D, Debus J, Abdollahi A, Gorlia T, Tonn JC, Weller M, Maier-Hein KH, Radbruch A, Wick W, Bendszus M, Meredig H, Kurz FT, Vollmuth P. Rastogi A, et al. Among authors: idbaih a. Lancet Oncol. 2024 Mar;25(3):400-410. doi: 10.1016/S1470-2045(23)00641-1. Lancet Oncol. 2024. PMID: 38423052 Free article.
Retraction Note: Neurocognitive impairment and patient-proxy agreement on health-related quality of life evaluations in recurrent high-grade glioma patients.
Caramanna I, Klein M, van den Bent M, Idbaih A, Wick W, Taphoorn MJB, Dirven L, Bottomley A, Reijneveld JC; EORTC Quality of Life Group and EORTC Brain Tumor Group. Caramanna I, et al. Among authors: idbaih a. Qual Life Res. 2024 Aug;33(8):2297. doi: 10.1007/s11136-024-03696-y. Qual Life Res. 2024. PMID: 38819763 Free PMC article. No abstract available.
The cerebral network of COVID-19-related encephalopathy: a longitudinal voxel-based 18F-FDG-PET study.
Kas A, Soret M, Pyatigoskaya N, Habert MO, Hesters A, Le Guennec L, Paccoud O, Bombois S, Delorme C; on the behalf of CoCo-Neurosciences study group and COVID SMIT PSL study group. Kas A, et al. Eur J Nucl Med Mol Imaging. 2021 Jul;48(8):2543-2557. doi: 10.1007/s00259-020-05178-y. Epub 2021 Jan 15. Eur J Nucl Med Mol Imaging. 2021. PMID: 33452633 Free PMC article.
Association between objective neurocognitive functioning and neurocognitive complaints in recurrent high-grade glioma: Longitudinal evidence of cognitive awareness from EORTC brain tumour trials.
Caramanna I, Reijneveld JC, van de Ven PM, van den Bent M, Idbaih A, Wick W, Taphoorn MJB, Dirven L, Bottomley A, Klein M; EORTC Quality of Life Group and EORTC Brain Tumor Group. Caramanna I, et al. Among authors: idbaih a. Eur J Cancer. 2023 Jun;186:38-51. doi: 10.1016/j.ejca.2023.02.029. Epub 2023 Mar 8. Eur J Cancer. 2023. PMID: 37028200
PARP inhibitors in gliomas: Mechanisms of action, current trends and future perspectives.
Cella E, Bosio A, Persico P, Caccese M, Padovan M, Losurdo A, Maccari M, Cerretti G, Ius T, Minniti G, Idbaih A, Sanai N, Weller M, Preusser M, Simonelli M, Lombardi G. Cella E, et al. Among authors: idbaih a. Cancer Treat Rev. 2024 Dec;131:102850. doi: 10.1016/j.ctrv.2024.102850. Epub 2024 Nov 5. Cancer Treat Rev. 2024. PMID: 39531943 Free article. Review.
Reappraisal of prognostic factors in CNS WHO grade 3 oligodendrogliomas IDH-mutant and 1p/19q co-deleted: lessons from the French POLA cohort.
Figarella-Branger D, Colin C, Mokhtari K, Uro-Coste E, Idbaih A, Appay R, Tabouret E, Touat M, Seyve A, Carpentier C, Dehais C, Ducray F; POLA network. Figarella-Branger D, et al. Among authors: idbaih a. Neuro Oncol. 2024 Oct 21:noae221. doi: 10.1093/neuonc/noae221. Online ahead of print. Neuro Oncol. 2024. PMID: 39432559
Updated EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection - Update 1.
van den Bent MJ, Franceschi E, Touat M, French PJ, Idbaih A, Lombardi G, Rudaà R, Schweizer L, Capper D, Sanson M, Wesseling P, Weller M, Eoli M, Anghileri E, Bielle F, Euskirchen P, Geurts M, Wen PY, Preusser M. van den Bent MJ, et al. Among authors: idbaih a. Neuro Oncol. 2024 Oct 10:noae213. doi: 10.1093/neuonc/noae213. Online ahead of print. Neuro Oncol. 2024. PMID: 39387386
312 results